Authors:
Dudley, ME
Wunderlich, J
Nishimura, MI
Yu, D
Yang, JC
Topalian, SL
Schwartzentruber, DJ
Hwu, P
Marincola, FM
Sherry, R
Leitman, SF
Rosenberg, SA
Citation: Me. Dudley et al., Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanoma, J IMMUNOTH, 24(4), 2001, pp. 363-373
Authors:
Orentas, RJ
Roskopf, SJ
Nolan, GP
Nishimura, MI
Citation: Rj. Orentas et al., Retroviral transduction of a T cell receptor specific for an Epstein-Barr virus-encoded peptide, CLIN IMMUNO, 98(2), 2001, pp. 220-228
Authors:
McKee, MD
Clay, TM
Diamond, RA
Rosenberg, SA
Nishimura, MI
Citation: Md. Mckee et al., Quantitation of T-cell receptor frequencies by competitive polymerase chain reaction: Dynamics of T-cell clonotype frequencies in an expanding tumor-infiltrating lymphocyte culture, J IMMUNOTH, 23(4), 2000, pp. 419-429
Authors:
Ladanyi, A
Nishimura, MI
Rosenberg, SA
Yang, JC
Citation: A. Ladanyi et al., Tumorigenicity and immunogenicity of murine tumor cells expressing an MHC class II molecule with a covalently bound antigenic peptide, J IMMUNOTH, 23(1), 2000, pp. 36-47
Authors:
Dudley, ME
Nishimura, MI
Holt, AKC
Rosenberg, SA
Citation: Me. Dudley et al., Antitumor immunization with a minimal peptide epitope (G9-209-2M) leads toa functionally heterogeneous CTL response, J IMMUNOTH, 22(4), 1999, pp. 288-298
Authors:
McKee, MD
Clay, TM
Rosenberg, SA
Nishimura, MI
Citation: Md. Mckee et al., Quantitation of T-cell receptor frequencies by competitive PCR: Generationand evaluation of novel TCR subfamily and clone specific competitors, J IMMUNOTH, 22(2), 1999, pp. 93-102
Authors:
Housseau, F
Bright, RK
Simonis, T
Nishimura, MI
Topalian, SL
Citation: F. Housseau et al., Recognition of a shared human prostate cancer-associated antigen by nonclassical MHC-restricted CD8+T cells, J IMMUNOL, 163(11), 1999, pp. 6330-6337
Authors:
Clay, TM
Custer, MC
Sachs, J
Hwu, P
Rosenberg, SA
Nishimura, MI
Citation: Tm. Clay et al., Efficient transfer of a tumor antigen-reactive TCR to human peripheral blood lymphocytes confers anti-tumor reactivity, J IMMUNOL, 163(1), 1999, pp. 507-513
Authors:
Clay, TM
Custer, MC
McKee, MD
Parkhurst, M
Robbins, PF
Kerstann, K
Wunderlich, J
Rosenberg, SA
Nishimura, MI
Citation: Tm. Clay et al., Changes in the fine specificity of gp100((209-217))-reactive T cells in patients following vaccination with a peptide modified at an HLA-A2.1 anchor residue, J IMMUNOL, 162(3), 1999, pp. 1749-1755
Authors:
Pieper, R
Christian, RE
Gonzales, MI
Nishimura, MI
Gupta, G
Settlage, RE
Shabanowitz, J
Rosenberg, SA
Hunt, DF
Topalian, SL
Citation: R. Pieper et al., Biochemical identification of a mutated human melanoma antigen recognized by CD4(+) T cells, J EXP MED, 189(5), 1999, pp. 757-765
Authors:
Nishimura, MI
Avichezer, D
Custer, MC
Lee, CS
Chen, C
Parkhurst, MR
Diamond, RA
Robbins, PF
Schwartzentruber, DJ
Rosenberg, SA
Citation: Mi. Nishimura et al., MHC class I-restricted recognition of a melanoma antigen by a human CD4(+)tumor infiltrating lymphocyte, CANCER RES, 59(24), 1999, pp. 6230-6238